New insight into how tissue factor allosterically regulates Factor VIIa

被引:25
作者
Eigenbrot, C
Kirchhofer, D
机构
[1] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Physiol, San Francisco, CA 94080 USA
关键词
D O I
10.1016/S1050-1738(01)00139-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Factor VIIa (FVIIa) is the coagulation protease responsible for starting a cascade of proteolytic events that lead to thrombin generation, and hence, to fibrin deposition and platelet activation. As such, it has attracted interest as a target for clinical anticoagulant therapy. Commensurate with the critical importance of maintaining balance between thrombosis and hemostasis and FVIIa'S place at the beginning of the coagulation process, FVIIa is subject to a variety of biological and biochemical control mechanisms, among them allosteric influences exerted by cofactors, substrates, and inhibitors. Essential for the proteolytic activity of FVIIa is its cofactor, Tissue Factor (TF). Major progress in elucidating the key influence of TF was made when the TF.FVIla structure was determined in 1996. However, a molecular explanation of an important aspect of TF's influence-its effect on the active site-was not available until the recent determination of a FVII zymogen structure. In this review we discuss the significance of unprecedented differences between these two structures in understanding the regulation of this important enzyme. (C) 2002, Elsevier Science Inc.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 79 条
  • [71] Regulation of the catalytic function of coagulation factor VIIa by a conformational linkage of surface residue Glu 154 to the active site
    Shobe, J
    Dickinson, CD
    Ruf, W
    [J]. BIOCHEMISTRY, 1999, 38 (09) : 2745 - 2751
  • [72] Factor VIIa modified in the 170 loop shows enhanced catalytic activity but does not change the zymogen-like property
    Soejima, K
    Mizuguchi, J
    Yuguchi, M
    Nakagaki, T
    Higashi, S
    Iwanaga, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) : 17229 - 17235
  • [73] Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor
    Sorensen, BB
    Persson, E
    Freskgard, PO
    Kjalke, M
    Ezban, M
    Williams, T
    Rao, LVM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (18) : 11863 - 11868
  • [74] TAMARY H, 1997, THROMB HAEMOST S, P413
  • [75] TAYLOR FB, 1991, CIRC SHOCK, V33, P127
  • [76] HUMAN FACTOR-VIIA AND ITS COMPLEX WITH SOLUBLE TISSUE FACTOR - EVALUATION OF ASYMMETRY AND CONFORMATIONAL DYNAMICS BY ULTRACENTRIFUGATION AND FLUORESCENCE ANISOTROPY DECAY METHODS
    WAXMAN, E
    LAWS, WR
    LAUE, TM
    NEMERSON, Y
    ROSS, JBA
    [J]. BIOCHEMISTRY, 1993, 32 (12) : 3005 - 3012
  • [77] Cellular effects of initiation of the extrinsic pathway of blood coagulation
    Wiiger, MT
    Prydz, H
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (08) : 360 - 365
  • [78] LOCALIZATION OF TISSUE FACTOR IN THE NORMAL VESSEL WALL AND IN THE ATHEROSCLEROTIC PLAQUE
    WILCOX, JN
    SMITH, KM
    SCHWARTZ, SM
    GORDON, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (08) : 2839 - 2843
  • [79] Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant
    Zhang, E
    St Charles, R
    Tulinsky, A
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1999, 285 (05) : 2089 - 2104